Jan Závora

Dr. Jan Závora

Clinical Microbiology and ATB Centre, General University Hospital in Prague, Prague, Praha, Hlavní Město, Czech Republic
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2017 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
TSTomáš Suchý
Tomáš Suchý
MŠMonika Šupová
Monika Šupová
EKEva Klapková
Eva Klapková
VAVaclava Adamkova
Vaclava Adamkova
Jan ZávoraJan Závora
Jan Závora
RPRichard Průša
Richard Průša

25 September 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
HBHelena Lahoda Brodska
Helena Lahoda Brodska
JKJiri Klempir
Jiri Klempir
Jan ZávoraJan Závora
Jan Závora
PKPavel Kohout
Pavel Kohout
Trace elements and vitamins, collectively known as micronutrients, are essential for basic metabolic reactions in the human body. Their deficiency or, on the contrary, an increased amount can lead to serious disorders. Research in recent years has shown that long-term abnormal levels of micronutrients may be involved in the etiopathogenesis of some neurological diseases. Acute and chronic alterations in micronutrient levels may cause other serious complications in neurological diseases. Our aim was to summarize the knowledge about micronutrients in relation to selected neurological diseases and comment on their importance and the possibilities of therapeutic intervention in clinical practice.

1 July 2019 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
TSTomáš Suchý
Tomáš Suchý
MŠMonika Šupová
Monika Šupová
PSPavla Sauerová
Pavla Sauerová
MKMarie Hubalek Kalbacova
Marie Hubalek Kalbacova
EKEva Klapková
Eva Klapková
LVLucie Vištejnová
Lucie Vištejnová

19 March 2019 in Journal of Bioactive and Compatible Polymers
Verified
Journal Article
Closed access
PDF file
PLPeter Lukáč
Peter Lukáč
JHJan Miroslav Hartinger
Jan Miroslav Hartinger
MMMikuláš Mlček
Mikuláš Mlček
MPMichaela Popková
Michaela Popková
TSTomáš Suchý
Tomáš Suchý
TGTomáš Grus
Tomáš Grus
Our study presents a novel collagen wound dressing prepared from freshwater fish skin (Cyprinus Carpio) collagen type I. Half of the sponges were cross-linked with carbodiimide. The cross-linked and non-cross-linked collagen sponges were subsequently impregnated with gentamicin and lyophilized thus allowing for the attainment of the appropriate gentamicin content without the removal thereof during the cross-linking stage. The structure was evaluated via micro-CT and infrared spectrometry and the structural stability and gentamicin release properties were evaluated in phosphate buffer solution. The sponges were further tested via a rat model of an infected wound with Pseudomonas aeruginosa inoculation and compared with a reference commercial product. The sponges thus prepared provided a degree of open porosity that was comparable to or higher than that of the reference commercial product. Spectrometry analysis revealed that the cross-linked collagen sponge and reference commercial product sponge preserved their secondary collagen structure after 168 h while early accelerated degradation was observed with respect to the non-cross-linked collagen sponge. Gentamicin was released rapidly from all the sponges. Compared to those animals with gentamicin-containing sponges or gentamicin administered intramuscularly, the animals with the cross-linked collagen sponge without gentamicin exhibited marked clinical and laboratory infection signs. Both the administration routes (intramuscular and via gentamicin-containing sponges) provided similar gentamicin plasma levels. The resulting highly homogeneous product which was characterized by excellent structural and clinical properties proved effective in terms of the treatment of a surgical wound infection in a rat model. We demonstrated that all the gentamicin was released from the sponge and was absorbed in the systemic circulation. This is the first time that Cyprinus Carpio collagen has been used in the preparation of wound dressings. Thus, gentamicin-containing sponges provide a promising tool for the treatment and prevention of surgical site infections.

29 November 2019 in Bosnian Journal of Basic Medical Sciences
Verified
Journal Article
Open access
PDF file
JHJan Miroslav Hartinger
Jan Miroslav Hartinger
PLPeter Lukáč
Peter Lukáč
PMPetr Mitáš
Petr Mitáš
MMMikuláš Mlček
Mikuláš Mlček
MPMichaela Popková
Michaela Popková
TGTomáš Grus
Tomáš Grus
The study presents a novel vancomycin-releasing collagen wound dressing derived from Cyprinus carpio collagen type I cross-linked with carbodiimide which retarded the degradation rate and increased the stability of the sponge. Following lyophilization, the dressings were subjected to gamma sterilization. The structure was evaluated via scanning electron microscopy images, micro-computed tomography, and infrared spectrometry. The structural stability and vancomycin release properties were evaluated in a phosphate buffer solution. Microbiological testing and a rat model of a wound infected with methicillin-resistant Staphylococcus aureus (MRSA) were then employed to test the efficacy of the treatment of the infected wound. Following an initial mass loss due to the release of vancomycin, the sponges remained stable. After 7 days of exposure in phosphate buffered saline (37°C), 60% of the material remained with a preserved collagen secondary structure together with a high degree of open porosity (over 80%). The analysis of the release of the vancomycin revealed the homogeneous distribution of the antibiotic both across and between the sponges. The release of vancomycin was retarded as proved by in vitro testing and further confirmed by the animal model from which measurable concentrations were observed in blood samples 24 hours after the subcutaneous implantation of the sponge, which was more than observed following i. p. administration. The sponge was also highly effective in terms of reducing the number of colony-forming units in biopsies extracted from the infected wounds 4 days following the inoculation of the wounds with the MRSA solution.

30 November 2018 in The Journal of Antibiotics
Verified
Journal Article
Closed access
PDF file
VVVladimir Vimberg
Vladimir Vimberg
RGRadek Gazak
Radek Gazak
ZSZsolt Szűcs
Zsolt Szűcs
ABAniko Borbás
Aniko Borbás
PHPal Herczegh
Pal Herczegh
GNGabriela Balikova Novotna
Gabriela Balikova Novotna